NSE · Basic Materials · Agricultural Inputs
| Document | Date |
|---|---|
| Annual report FY2026 INDO US BIO-TECH LIMITED - ANNUAL REPORT SUMMARY (FY 2025-2026) HEADLINE NUMBERS • Company: Indo Us Bio-Tech Limited, a seed business company based | 2026-09-05 |
| Quarterly results · Q1 FY27 INDO-US BIO-TECH LIMITED – Q1 FY2026-27 FINANCIAL SUMMARY HEADLINE NUMBERS • Q1 FY2027 Revenue from Operations: Rs 3,208.68 crore (vs Rs 2,602.47 cr | 2026-08-12 |
| Quarterly results · Q4 FY26 INDO US BIO-TECH LIMITED – FINANCIAL SUMMARY FOR RETAIL INVESTORS HEADLINE NUMBERS • Year Ended 31 March 2026 Revenue: Rs 11,043.91 lakhs (FY2025: R | 2026-05-29 |
| Quarterly results · Q3 FY26 INDO US BIO TECH LIMITED – DOCUMENT SUMMARY HEADLINE NUMBERS • Reporting Period: Quarter ended 30-September-2025 • Document Date: 16-February-2026 • | 2026-02-16 |
| Quarterly results · Q2 FY26 INDO US BIO-TECH LIMITED - DOCUMENT SUMMARY HEADLINE NUMBERS • Board meeting held on November 14, 2025 approved unaudited financial results for quar | 2025-11-15 |
| Annual report FY2025 INDO US BIO-TECH LIMITED – 21ST ANNUAL REPORT 2024-25 SUMMARY HEADLINE NUMBERS • Total Revenue (FY 2024-25): Rs. 1,04,02,03,729 vs Rs. 73,15,58,235 | 2025-08-28 |
| Quarterly results · Q1 FY26 INDO US BIO-TECH LIMITED – DOCUMENT SUMMARY HEADLINE NUMBERS • Quarter ended 30th June 2025 unaudited financial results approved by Board on 12th Au | 2025-08-13 |
| Quarterly results | 2025-03-25 |
Readable in the app.
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Indo Us Bio-Tech Limited — free to start.
Google PlayApp StoreData updated 2026-09-18.